Penn third-year named 2024 Udall Scholar Third-year undergraduate Joey Wu has been named a 2024 Udall Scholar.(Image: Courtesy of the Center for Undergraduate Research and Fellowships) Penn third-year named 2024 Udall Scholar Third-year Joey Wu, studying bioengineering and environmental science in the Vagelos Integrated Program in Energy Research (VIPER) program, has been named a 2024 Udall Scholar.
A novel technique to form human artificial chromosomes Image: iStock/Mohammed Haneefa Nizamudeen A novel technique to form human artificial chromosomes Penn researchers say the new technique for making human artificial chromosomes from single, long constructs of designer DNA will allow for more efficient laboratory research.
Sherry Gao pushes the boundaries of genetic engineering Sherry (Xue) Gao, Presidental Penn Compact Associate Professor in Bioengineering. (Image: Courtesy of Penn Engineering Today) Sherry Gao pushes the boundaries of genetic engineering The Presidential Penn Compact Associate Professor in Chemical and Biomolecular Engineering aims to make gene editing tools like CRISPR more accurate, and encourage first generation students along the way.
Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Image: iStock/Love Employee Accelerating CAR T cell therapy: Lipid nanoparticles speed up manufacturing Penn Engineers have developed a novel method for manufacturing CAR T cells using lipid nanoparticles as delivery vehicles.
New molecules, inspired by space shuttles, advance lipid nanoparticle delivery for weight control Like space shuttles using booster rockets to breach the atmosphere, lipid nanoparticles equipped with the new molecule more successfully deliver medicinal payloads. (Image: Courtesy of Penn Engineering) New molecules, inspired by space shuttles, advance lipid nanoparticle delivery for weight control Penn Engineering researchers have invented a new way to synthesize the key chemical components of lipid nanoparticles that help protect and deliver medicinal payloads.
Can your personal medical devices be recycled? Penn In the News The New York Times Can your personal medical devices be recycled? A lab at the School of Engineering and Applied Science led the development of a COVID test made from bacterial cellulose, an organic compound. ‘Switchable’ bispecific antibodies pave way for safer cancer treatment Bispecific T cell engagers are emerging as a powerful class of immunotherapy to treat cancer but are sometimes hindered by unwanted outcomes, such as on-target, off-tumor toxicity; cytokine release syndrome; and neurotoxicity. Now, researchers Penn researchers have developed a novel “switchable” bispecific T cell engager that mitigates these negative effects by co-opting a drug already approved by the FDA. (Image: iStock / CIPhotos) ‘Switchable’ bispecific antibodies pave way for safer cancer treatment Immunotherapy utilizing an FDA-approved drug has enabled Penn researchers to develop a novel switchable bispecific T cell engager that mitigates negative outcomes of immunotherapy. Illuminating the invisible: Bringing the smallest protein clusters into focus Image: iStock/freedarst Illuminating the invisible: Bringing the smallest protein clusters into focus Penn engineers are opening new avenues for detecting the proteins implicated in diseases like Alzheimer’s and testing new treatments. Noor Momin harnesses the immune system to treat heart disease Image: Kjpargeter for Shutterstock Noor Momin harnesses the immune system to treat heart disease The Stephenson Foundation Term Assistant Professor of Innovation and her lab members work to engineer nanoparticles as medicinal vehicles to fit directly into a single cell. Scientists think they’re on the verge of breaching the blood-brain barrier Penn In the News Science Alert Scientists think they’re on the verge of breaching the blood-brain barrier Michael Mitchell of the School of Engineering and Applied Science and colleagues have constructed a model that could potentially allow drug transporters to bypass the blood-brain barrier. Load More
‘Switchable’ bispecific antibodies pave way for safer cancer treatment Bispecific T cell engagers are emerging as a powerful class of immunotherapy to treat cancer but are sometimes hindered by unwanted outcomes, such as on-target, off-tumor toxicity; cytokine release syndrome; and neurotoxicity. Now, researchers Penn researchers have developed a novel “switchable” bispecific T cell engager that mitigates these negative effects by co-opting a drug already approved by the FDA. (Image: iStock / CIPhotos) ‘Switchable’ bispecific antibodies pave way for safer cancer treatment Immunotherapy utilizing an FDA-approved drug has enabled Penn researchers to develop a novel switchable bispecific T cell engager that mitigates negative outcomes of immunotherapy.
Illuminating the invisible: Bringing the smallest protein clusters into focus Image: iStock/freedarst Illuminating the invisible: Bringing the smallest protein clusters into focus Penn engineers are opening new avenues for detecting the proteins implicated in diseases like Alzheimer’s and testing new treatments.
Noor Momin harnesses the immune system to treat heart disease Image: Kjpargeter for Shutterstock Noor Momin harnesses the immune system to treat heart disease The Stephenson Foundation Term Assistant Professor of Innovation and her lab members work to engineer nanoparticles as medicinal vehicles to fit directly into a single cell.
Scientists think they’re on the verge of breaching the blood-brain barrier Penn In the News Science Alert Scientists think they’re on the verge of breaching the blood-brain barrier Michael Mitchell of the School of Engineering and Applied Science and colleagues have constructed a model that could potentially allow drug transporters to bypass the blood-brain barrier.